AI Article Synopsis

  • Benign paroxysmal positional vertigo (BPPV) is a common cause of vertigo, and this systematic review aims to assess the effectiveness of the particle repositioning maneuver in resolving benign paroxysmal positional nystagmus (BPPN) after treatment in patients with posterior canal BPPV.
  • The review analyzed data from various studies, revealing that the canalith repositioning procedure (CRP) had significantly higher odds of resolving BPPN compared to sham treatments, with findings supported by additional quasi-randomized trials.
  • Limitations of the review included variations in the methodological quality of the studies included, which may affect the reliability of the findings.

Article Abstract

Background: Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo.

Purpose: The purpose of this systematic review was to determine whether patients diagnosed with posterior canal (PC) BPPV, based on positional testing, and treated with a particle repositioning maneuver will show the resolution of benign paroxysmal positional nystagmus (BPPN) on the Dix-Hallpike Test performed 24 hours or more after treatment.

Data Sources: Data were obtained from an electronic search of the MEDLINE, EMBASE, and CINAHL databases from 1966 through September 2009.

Study Selection: The study topics were randomized controlled trials (RCTs), quasi-RCTs, the diagnosis of PC BPPV, treatment with the particle repositioning maneuver, and outcome measured with a positional test 24 hours or more after treatment.

Data Extraction: Data extracted were study descriptors and the information used to code for effect size.

Data Synthesis: In 2 double-blind RCTs, the odds in favor of the resolution of BPPN were 22 times (95% confidence interval=3.41-141.73) and 37 times (95% confidence interval=8.75-159.22) higher in people receiving the canalith repositioning procedure (CRP) than in people receiving a sham treatment. This finding was supported by the results reported in 8 nonmasked quasi-RCTs. Studies with limited methodological quality suggested that a liberatory maneuver (LM) was more effective than a control intervention; there was no significant difference in the effectiveness of the LM and the effectiveness of the CRP; the self-administered CRP was more effective than the self-administered LM; and the CRP administered together with the self-administered CRP was more effective than the CRP administered alone. The Brandt-Daroff exercises were the least effective self-administered treatments.

Limitations: The limitations included the methodological quality of the studies, the lack of quality-of-life measures, and confounding factors in reporting vertigo.

Conclusions: Randomized controlled trials provided strong evidence that the CRP resolves PC BPPN, and quasi-RCTs suggested that the CRP or the LM performed by a clinician or with proper instruction at home by the patient resolves PC BPPN. There were no data on the effects of the maneuvers on outcomes relevant to patients.

Download full-text PDF

Source
http://dx.doi.org/10.2522/ptj.20090071DOI Listing

Publication Analysis

Top Keywords

particle repositioning
12
benign paroxysmal
12
paroxysmal positional
12
self-administered crp
12
positional vertigo
8
systematic review
8
repositioning maneuver
8
hours treatmentdata
8
randomized controlled
8
controlled trials
8

Similar Publications

Cubosomes as Delivery System to Repositioning Nitrofurantoin in Breast Cancer Management.

Drug Des Devel Ther

December 2024

Department of Pharmaceutical Technology, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt.

Purpose: Nitrofurantoin (NITRO), a long-standing antibiotic to treat urinary tract infections, is activated by Nitro reductases. This activation mechanism has led to its exploration for repositioning applications in controlling and treating breast cancer, which express a Nitro reductase gene.

Methods: NITRO Cubosomes were developed using hot homogenization according to 2-full factorial design.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers created sodium alginate-poloxamer microparticles to enhance niclosamide's solubility and bioavailability through spray drying techniques, experimenting with different formulations.
  • The study found that the new amorphous microparticles significantly improved both the drug's solubility (up to 1775 times) and oral bioavailability (about 5.6 times) compared to the original powder form, making them promising for future cancer treatment applications.
View Article and Find Full Text PDF

Objective: Benign Paroxysmal Positional Vertigo is a vestibular disorder causing vertigo and imbalance. This systematic review and meta-analysis aims to explore the impact of benign paroxysmal positioning vertigo and repositioning maneuvers on postural control.

Data Sources: In September 2024, PubMed, Web of Science, Scopus and reference lists of included studies were systematically searched.

View Article and Find Full Text PDF

This study presents a preliminary examination of the effects of environment changes post-excavation on heavily corroded archaeological Roman iron nails using neutron tomography and image registration techniques. Roman nails were exposed to either a high relative humidity environment, or fast thermal drying as primary experiments to show the power of this imaging technique to monitor and quantify the structural changes of corroded metal artifacts. This research employed a series of pre- and post-treatment tomography acquisitions (time-series) complemented by advanced image registration methods.

View Article and Find Full Text PDF

Pimozide-loaded nanostructured lipid carriers: Repurposing strategy against lung cancer.

Sci Prog

November 2024

Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.

Article Synopsis
  • The study focused on repurposing pimozide (PMZ) by embedding it in nanostructured lipid carriers (NLC) using a specialized method to enhance drug delivery.
  • The formulated NLCs showed favorable characteristics, including a small particle size, suitable zeta potential, and high encapsulation efficiency, alongside demonstrating pH-sensitive drug release and improved anticancer effects on A549 cell lines.
  • The results indicate that PMZ-NLC could be a promising and effective option for targeted lung cancer therapy, warranting further research into its safety and clinical use.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!